சீரம் இன்ஸ்டிடியூட், இந்தியா (Tamil Wikipedia)

Analysis of information sources in references of the Wikipedia article "சீரம் இன்ஸ்டிடியூட், இந்தியா" in Tamil language version.

refsWebsite

Global rank Tamil rank

4indiatimes.com

17^th place

9^th place

3seruminstitute.com

low place

low place

2^nd place

4^th place

4^th place

5^th place

2indianexpress.com

60^th place

24^th place

1vpm-consult.com

low place

low place

1thepharmaletter.com

low place

low place

99^th place

319^th place

low place

2,291^st place

1web.archive.org

1^st place

1^st place

70^th place

248^th place

54^th place

127^th place

6,454^th place

1,056^th place

20^th place

18^th place

1financialexpress.com

798^th place

252^nd place

52^nd place

2^nd place

bbc.com

கொரோனா தடுப்பூசி: இந்தியாவின் சீரம் நிறுவன தடுப்பூசி பரிசோதனை

bloomberg.com

"Serum Institute of India Pvt. Ltd.: Private Company Information". bloomberg.com. Retrieved 2018-09-30.

doi.org

dx.doi.org

Kulkarni, Prasad S.; Raut, Sidram K.; Dhere, Rajeev M. (27 October 2014). "A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac ®) in India". Human Vaccines & Immunotherapeutics 9 (1): 122–124. doi:10.4161/hv.22317. பப்மெட்:23442586.
Kulkarni, Prasad S.; Sahai, Ashish; Gunale, Bhagwat; Dhere, Rajeev M (3 March 2017). "Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd". Expert Review of Vaccines 16 (4): 303–311. doi:10.1080/14760584.2017.1294068. பப்மெட்:28276304.

financialexpress.com

"Covid-19 vaccine: Serum Institute signs up for 100 million doses of vaccines for India, low and middle-income countries". The Financial Express. 7 August 2020. https://www.financialexpress.com/lifestyle/health/covid-19-vaccine-serum-institute-signs-up-for-100-million-doses-of-vaccines-for-india-low-and-middle-income-countries/2047884/.

forbes.com

"Cyrus Poonawalla on Forbes Lists". Forbes. Retrieved 24 March 2015.

iitk.ac.in

"Vaccination Schedule". Vaccination as per the National Immunization schedule by Government of India. Retrieved 2020-06-15.

indianexpress.com

"Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca corona vaccine production starts; US says 2 billion doses ‘ready to go’" (in en). The Indian Express. 10 June 2020. https://indianexpress.com/article/coronavirus/corona-covid-19-vaccine-update-june-oxford-astrazeneca-moderna-serum-institute-of-india-6447030/.
"Serum Institute of India to provide Covid-19 vaccines through COVAX at Rs 225 a dose" (in en). The Indian Express. 7 August 2020. https://indianexpress.com/article/india/sii-to-provide-covid-19-vaccines-through-covax-at-rs-225-a-dose-india-6544158/.

indiatimes.com

economictimes.indiatimes.com

"Poonawalla Investments AND Industries Private Limited Information - Poonawalla Investments AND Industries Private Limited Company Profile, Poonawalla Investments AND Industries Private Limited News on The Economic Times". The Economic Times. Archived from the original on 2019-05-08. Retrieved 2020-07-10.
"AstraZeneca & Serum Institute of India sign licensing deal for 1 million doses of Oxford vaccine". The Economic Times. https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-serum-institute-of-india-sign-licensing-deal-for-1-billion-doses-of-oxford-vaccine/articleshow/76202016.cms.

timesofindia.indiatimes.com

"India developing indigenous swine flu vaccine". The Times of India. Retrieved 1 February 2015.
"Fast-acting anti-rabies drug set for India launch - Times of India". The Times of India. Retrieved 2016-06-12.

loc.gov

webarchive.loc.gov

"Poonawalla Investments AND Industries Private Limited Information - Poonawalla Investments AND Industries Private Limited Company Profile, Poonawalla Investments AND Industries Private Limited News on The Economic Times". The Economic Times. Archived from the original on 2019-05-08. Retrieved 2020-07-10.

nih.gov

ncbi.nlm.nih.gov

Kulkarni, Prasad S.; Raut, Sidram K.; Dhere, Rajeev M. (27 October 2014). "A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac ®) in India". Human Vaccines & Immunotherapeutics 9 (1): 122–124. doi:10.4161/hv.22317. பப்மெட்:23442586.
Kulkarni, Prasad S.; Sahai, Ashish; Gunale, Bhagwat; Dhere, Rajeev M (3 March 2017). "Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd". Expert Review of Vaccines 16 (4): 303–311. doi:10.1080/14760584.2017.1294068. பப்மெட்:28276304.

seruminstitute.com

"About Us". Serum Institute of India. Archived from the original on 19 நவம்பர் 2016. Retrieved 8 December 2016.
"Serum Institute Tubervac (BCG)". Serum Institute of India. Retrieved 2020-06-15.
"Serum Institute Poliovac". Serum Institute of India. Retrieved 2020-06-15.

thehindu.com

Banerjee, Shoumojit (7 July 2020). "Oxford COVID-19 vaccine at least 6 months away from launch: Serum Institute CEO" (in en-IN). The Hindu. https://www.thehindu.com/news/national/oxford-covid-19-vaccine-at-least-6-months-away-from-launch-serum-institute-ceo/article32015508.ece.

thepharmaletter.com

"Bilthoven Biologicals acquired by Serum Institute of India". www.thepharmaletter.com. Retrieved 2020-07-10.

vpm-consult.com

"Profile". www.vpm-consult.com. Retrieved 2020-07-10.

web.archive.org

"About Us". Serum Institute of India. Archived from the original on 19 நவம்பர் 2016. Retrieved 8 December 2016.

zaubacorp.com

"SERUM INSTITUTE OF INDIA PRIVATE LIMITED - Company, directors and contact details". zaubacorp.com (in ஆங்கிலம்). Retrieved 2018-09-30.